Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects.

导出 LinkOut

翻译打印收藏纠错

作者： Woo Yul,Lee ^[1] ; EunSil,Oh ^[2] ; Mengqi,Cui ^[2] ; Choon Ok,Kim ^[2] ; Yeji,Lim ^[2] ; Hunam,Kim ^[3] ; Hyeonsoo,Park ^[3] ; Sukyong,Yoon ^[1] ; Min Soo,Park ^[2] ; Taegon,Hong ^[1]

作者单位： Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Korea. ^[1] Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea. ^[2] Yuhan Research Institute, Yuhan Corporation, Seoul 06927, Korea. ^[3] Department of Pediatrics, Yonsei University College of Medicine, Seoul 03722, Korea. ^[4]

关键词 Drug interactions Helicobacter pylori Pharmacokinetics Potassium-competitive acid blocker Triple therapy

DOI 10.12793/tcp.2020.28.e5

PMID 32274381

发布时间 2022-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational and clinical pharmacology

2020年28卷1期

55-65页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects.

Translational and clinical pharmacology

相似文献

Translational and clinical pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects.

Translational and clinical pharmacology

相似文献

Translational and clinical pharmacology

相关期刊

检索历史清除